Cardiovascular involvement in connective tissue disease: the role of interstitial lung disease

• Published in: PloS one Vol. 10; no. 3; p. e0121976
• Main Authors: Wang, XiaoBing, Lou, MeiNa, Li, Yongji, Ye, WenJing, Zhang, ZhiYong, Jia, Xiufen, Shi, HongYing, Zhu, XiaoChun, Wang, LiangXing
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 16.03.2015; Public Library of Science (PLoS)
• Subjects: Acids; Adult; Aged; Alveoli; Atherosclerosis; Autoimmune diseases; Blood pressure; Body mass; Body mass index; Body size; C-reactive protein; Cardiac patients; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - diagnosis; Cardiovascular Diseases - drug therapy; Cardiovascular Diseases - epidemiology; Cardiovascular Diseases - etiology; Case-Control Studies; Cholesterol; Complications; Computed tomography; Connective Tissue Diseases - complications; Connective Tissue Diseases - drug therapy; Connective Tissue Diseases - epidemiology; Connective tissues; Demographics; Diabetes mellitus; Dosage; Echocardiography; Enrollments; Female; Glucocorticoids; Glucose; Health care; Health risk assessment; Health risks; Hospitals; Humans; Hyperlipidemia; Hypertension; Inflammation; Low density lipoproteins; Lung diseases; Lung Diseases, Interstitial - complications; Lung Diseases, Interstitial - epidemiology; Lungs; Lupus; Male; Medical records; Medical screening; Middle Aged; Mortality; Multivariate analysis; Patients; Retrospective Studies; Rheumatism; Rheumatoid arthritis; Rheumatology; Risk; Studies; Systolic pressure; Tomography; Uric acid; China
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0121976

The aim of this study was to assess cardiovascular involvement in patients with connective tissue disease (CTD), and determine whether interstitial lung disease (ILD) in these patients is associated with elevated cardiovascular risk. This study evaluated a retrospective cohort of 436 CTD patients admitted to a large teaching hospital in Zhejiang province, China, along with an additional 436 participants of an annual community health screening conducted in the physical examination center who served as age- and gender-matched controls. Demographic, clinical, serologic and imaging characteristics, as well as medications used by each participant were recorded. Cardiovascular involvement was defined by uniform criteria. Correlations between clinical/serologic factors and cardiovascular involvement were determined by univariate and multivariate analyses. CTD patients had a significantly higher cardiovascular involvement rate than controls (64.7% vs 23.4%), with higher rates of diabetes, hypertension, and hyperlipidemia, elevated systolic and diastolic pressures, C-reactive protein, total cholesterol, and low-density lipoprotein cholesterol, and lower albumin and high-density lipoprotein cholesterol (all p < 0.05). Furthermore, CTP patients with cardiovascular involvement were significantly older, had higher systolic and diastolic pressures, C-reactive protein, glucose, and uric acid, higher rates of diabetes, hypertension, and use of moderate- to high-dose glucocorticoids, and longer disease duration compared to patients without involvement (all p < 0.05). Moreover, CTD in patients with cardiovascular involvement was more likely to be complicated by ILD (p < 0.01), which manifested as a higher alveolar inflammation score (p < 0.05). In the multivariate analysis, cardiovascular involvement in CTD patients was associated with age, systolic pressure, body mass index, uric acid, disease duration > 2 years, use of moderate- to high-dose glucocorticoids, and ILD with a high alveolar inflammation score. Cardiovascular involvement is increased in CTD patients, and is associated with ILD with a higher alveolar inflammation score. Thus, early-stage echocardiography and CT scans should be used to detect potential cardiovascular complications in these patients.